As of Feb 21
| -0.05 / -2.56%|
The 4 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 8.00 and a low estimate of 4.00. The median estimate represents a +163.16% increase from the last price of 1.90.
The current consensus among 4 polled investment analysts is to Buy stock in Idera Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.